LYRA Lyra Therapeutics, Inc.
Healthcare · Market cap: $337.2K
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $46.5M | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $17.8M | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $74.0K | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $20.0K |
| 2025-Q4 | $0 | $526.8K |
| 2026-Q1 | $0 | $8.3K |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$64.4M11 buy days
Sold$555.1K10 sell days
Net insider flow+$63.8Mnet buying · 5 years
Latest trade2026-01-06Palasis Maria
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-01-06 | Sell | Palasis Maria | CEO | 1,702 | $3.36 | $5.7K | 1 |
| 2026-01-06 | Sell | Cavalier Jason | CFO | 769 | $3.36 | $2.6K | 1 |
| 2025-11-13 | Sell | EDELMAN JOSEPH | 10% owner | 31,810 | $3.90 | $124.1K | 2 |
| 2025-11-12 | Sell | EDELMAN JOSEPH | 10% owner | 8,745 | $4.06 | $35.5K | 2 |
| 2025-11-11 | Sell | EDELMAN JOSEPH | 10% owner | 5,320 | $4.31 | $22.9K | 2 |
| 2025-11-10 | Sell | EDELMAN JOSEPH | 10% owner | 18,502 | $4.54 | $84.0K | 2 |
| 2025-11-07 | Sell | EDELMAN JOSEPH | 10% owner | 19,739 | $4.75 | $93.8K | 2 |
| 2025-11-06 | Sell | EDELMAN JOSEPH | 10% owner | 32,149 | $5.18 | $166.5K | 2 |
| 2025-07-10 | Sell | Palasis Maria | CEO | 1,565 | $8.91 | $13.9K | 1 |
| 2025-07-10 | Sell | Cavalier Jason | CFO | 684 | $8.91 | $6.1K | 1 |
| 2023-11-10 | Buy | Waksal Harlan | Chair | 25,000 | $2.96 | $74.0K | 1 |
| 2023-05-31 | Buy | EDELMAN JOSEPH | Director | 3,610,832 | $2.49 | $9.0M | 1 |
| 2023-05-31 | Buy | ANDERSON EDWARD T | Director | 1,805,416 | $2.43 | $4.4M | 3 |
| 2023-05-31 | Buy | NORTH BRIDGE VENTURE PARTNERS V-B LP | 10% owner | 1,805,416 | $2.43 | $4.4M | 3 |
| 2022-06-10 | Buy | MERRIFIELD C ANN | Director | 4,000 | $5.05 | $20.2K | 1 |
| 2022-05-16 | Buy | MERRIFIELD C ANN | Director | 328 | $5.00 | $1.6K | 1 |
| 2022-05-13 | Buy | MERRIFIELD C ANN | Director | 3,500 | $4.81 | $16.8K | 1 |
| 2022-04-12 | Buy | EDELMAN JOSEPH | Director | 5,924,170 | $4.22 | $25.0M | 1 |
| 2022-04-12 | Buy | ANDERSON EDWARD T | Director | 2,488,150 | $4.22 | $10.5M | 4 |
| 2022-04-12 | Buy | NORTH BRIDGE VENTURE PARTNERS V-B LP | 10% owner | 2,369,667 | $4.22 | $10.0M | 3 |
| 2022-04-12 | Buy | Waksal Harlan | Chair | 236,966 | $4.22 | $1,000.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| EDELMAN JOSEPH | 10% owner | $34.0M | $526.8K | 2025-11-13 |
| ANDERSON EDWARD T | Director | $14.9M | $0 | 2023-05-31 |
| NORTH BRIDGE VENTURE PARTNERS V-B LP | 10% owner | $14.4M | $0 | 2023-05-31 |
| Waksal Harlan | Chair | $1.1M | $0 | 2023-11-10 |
| MERRIFIELD C ANN | Director | $38.7K | $0 | 2022-06-10 |
| Palasis Maria | CEO | $0 | $19.7K | 2026-01-06 |
| Cavalier Jason | CFO | $0 | $8.7K | 2026-01-06 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2023-05-31 | 3 | $17.8M | 63 | +21.1% (+22.3% raw) | +7.6% (+11.0% raw) | +7.1% (+11.0% raw) | closed |
| 2022-04-12 | 4 | $46.5M | 50 | -24.4% (-32.4% raw) | -14.6% (-24.3% raw) | -26.9% (-39.5% raw) | closed |
| 2020-05-05 | 5 | $21.5M | 47 | -14.2% (-1.9% raw) | -32.9% (-16.2% raw) | -54.7% (-34.3% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.